suvorexant
Published research on suvorexant.

A 2026 narrative review says sedating antidepressants fit trouble falling asleep with anxiety or poor appetite, while orexin blockers fit night waking. Evidence in active depression is limit…
Read article →Belsomra (Suvorexant) is a drug that was approved by the FDA in 2014 for the treatment of insomnia. It didn’t hit the market until 2015 and is regarded as the first of a new generation of sl…
Read article →Some sources estimate that nearly 60 million Americans have difficulties falling asleep a.k.a. a condition known as insomnia. There are many causes of insomnia, including circadian rhythm di…
Read article →